Drug hypersensitivity is a difﬁcult problem, but recent advances in the genetics and understanding of the immune mechanisms of various drug hypersensitivity reactions have enabled the ﬁeld to make signiﬁcant progress. In Rome, geneticists, immunologists, pharmacologists, toxicologists, and allergists, many of whom belong to the European Network for Drug Allergy (ENDA), the EAACI interest group on drug hypersensitivity, met and discussed these new developments in a friendly and productive atmosphere.
|Numero di pagine||1|
|Rivista||JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY|
|Stato di pubblicazione||Pubblicato - 2011|